We hypothesized that, compared with low levels of circulating Apo A-1 and Apo B, respectively, high levels of circulating Apo A-1 would be associated with better prognosis of breast cancer, and that high levels of circulating Apo B would be associated with worse prognosis. Here, APOB is linked to breast cancer.